Silk Road Medical (SILK) Climbs 6.57% on May 13

Equities Staff  |

Silk Road Medical Inc (NASDAQ: SILK) shares have risen 6.57%, or $1.85 per share, as on 12:07:32 est today. Since opening at $29.04, 125,131 shares of Silk Road Medical have been traded today and the stock has traded between $30.12 and $28.64.  

Already this year the company is down 33.94%.

Silk Road Medical is set to release earnings on 2022-07-28.

For technical charts, analysis, and more on Silk Road Medical visit the company profile.

About Silk Road Medical Inc

Silk Road Medical, Inc.,is a medical device company located in Sunnyvale, California, that is focused on reducing the risk of stroke and its devastating impact. The company's flagship procedure, TransCarotid Artery Revascularization (TCAR), is clinically proven to treat blockages in the carotid artery at risk of causing a stroke.

To get more information on Silk Road Medical Inc and to follow the company's latest updates, you can visit the company's profile page here: Silk Road Medical Inc's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Trending Articles

Big Lots Down 18% in Premarket Trading Friday on Surprise Missed Earnings
Modine Posts Strong Rebound in Fiscal Q4, Raises 2023 Guidance
Dollar Tree Posts Record First Quarter, Leads Nasdaq Gainers
Kohl's Still in Play To Be Acquired
Chinook Therapeutics Raises $105 Million for Kidney Disease Therapies
Market Conditions Driving Higher Base Level for VIX Volatility Index
Will New AT&T, Dish Co-opetition Deal Work: Jeff Kagan
Cisco Down 12% in Premarket Trading Thursday After Top Line Miss and Lower Forecast



Market Movers

Sponsored Financial Content